Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NAT10 as an acetyltransferase to promote erythropoiesis

ABSTRACT: Understanding erythropoiesis involves comprehending the process of erythroid differentiation, yet there are still numerous mysteryin this field.The purpose of this research was to look at NAT10-mediated regulation of gene expression during erythroid differentiation. NAT10, an acetyltransferase, has been shown to be highly expressed in the early stages of erythroid differentiation and to play an important role in stimulating erythroid differentiation.We identified ac4C modification on RAC2 and GDF15 mRNAs by acetylated RNA immunoprecipitation sequencing (acRIP-seq) and ribosome profiling sequencing (Ribo-seq) combined with RNA sequencing, which are significant downstream targets of NAT10 to improve erythropoiesis . Collectively, our data suggest that NAT10 promotes erythropoiesis by acetylating RAC2 and GDF15 mRNA associated with erythroid progenitors, thereby promoting erythroid differentiation by increasing RNA stability and translation efficiency. This study reveals unexpected patterns in the regulation of erythroid differentiation, advances our understanding of the regulatory network for erythroid differentiation from multiple perspectives, and identifies potential clinical targets for controlling erythroid regeneration.

ORGANISM(S): Homo sapiens

PROVIDER: GSE237926 | GEO | 2026/07/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Identification of NAT10 targets in CRC by RNA immunoprecipitation and acethyl-RNA immunoprecipitation

Project description:To identify potential mRNAs that are acetylated by NAT10, RIP with a NAT10 antibody and acRIP with a ac4C antibody were conducted in DLD-1 and SW480 cells

2022-12-27 | GSE210385 | GEO

RNA-seq and acRIP-seq in NAT10 overexpression HaCaT cells [RIP-seq]

Project description:To elucidate the function of the RNA acetyltransferase NAT10 in keratinocytes and its regulatory impact on atopic dermatitis pathogenesis, we conducted RNA-seq and acRIP-seq of HaCaT cells overexpressing NAT10 versus empty-vector controls.

2026-06-09 | GSE304279 | GEO

RNA-seq and acRIP-seq in NAT10 overexpression HaCaT cells [RNA-seq]

2026-06-09 | GSE304278 | GEO

The underlying mechanism by which NAT10 exerted carcinogenesis and its potential targets in MM

Project description:An acRIP experiment was performed in KMS28-PE WT and KMS28-PE NAT10-OE cells. We compared the peak summit of KMS28-PE WT and KMS28-PE NAT10 OE cells to find the differences between KMS28-PE WT and KMS28-PE NAT10 OE cells.

2024-06-01 | GSE199524 | GEO

ac4C RIP-seq analysis of AGS cells upon NAT10 knockout.

Project description:N4-acetylcytidine (ac4C), a conserved chemical modification in eukaryotic prokaryotes that is catalyzed by the N-acetyltransferase 10 (NAT10) enzyme, plays a crucial role in promoting mRNA stability and translation. However, the biological function and mechanisms of NAT10-mediated ac4C in human cancer were poorly defined. In order to investigate the regulatory mechanism of NAT10 in gastric cancer, we performed ac4C RIP-seq(acRIP-seq) analysis in AGS cells with NAT10 knockout compared with control in two repeats.

2024-07-07 | GSE180494 | GEO

NAT10 Promotes Vascular Remodeling via mRNA Ac4c Acetylation

Project description:Vascular smooth muscle cells (VSMCs) phenotype switching is a pathological hallmark in various cardiovascular diseases. N4-acetylcytidine (ac4C), catalyzed by N-acetyltransferase 10 (NAT10), is well conserved in the enzymatic modification of RNA. NAT10-mediated ac4C acetylation is involved in various physiological and pathological processes, including cardiac remodeling. However, the biological functions and underlying regulatory mechanisms of mRNA ac4C modifications in vascular diseases remain elusive. By combining in vitro and in vivo vascular injury models, we identified NAT10 as a crucial protein involved in the promotion of postinjury neointima formation as well as VSMCs proliferation. The potential mechanisms of NAT10 in vascular neointima formation were clarified by RNA sequence (RNA-seq), acetylated mRNA immunoprecipitation sequence (acRIP-seq), and RNA binding protein immunoprecipitation sequence (RIP-seq). NAT10 and ac4C modification were upregulated in injured human and rodent arteries. Deletion of NAT10 in VSMCs effectively reduces postinjury neointima formation and VSMCs phenotype switching. Further RNA-seq, RIP-seq, and acRIP-seq revealed that NAT10, by its ac4C modification, directly interacts with genes, including integrin-β1 (ITGB1) and collagen type I alpha 2 chain (Col1a2) mRNAs. NAT10-mediated ac4C consequently increased ITGB1 mRNA stability and its downstream focal adhesion kinase (FAK) signaling, thereby directly influencing the proliferation of VSMCs and vascular remodeling. The regulation of NAT10 on VSMC phenotype is of translational significance because administration of remodelin, a NAT10 inhibitor, effectively prevents neointima formation by suppressing VSMCs proliferation and downregulating of ITGB1 expression and deactivating its FAK signaling. Our study reveals that NAT10 promotes vascular remodeling via mRNA Ac4c acetylation, which may be a promising therapeutic target against vascular remodeling.

2026-07-20 | GSE272001 | GEO

N-acetyltransferase NAT10 Controls Cell Fates via RNA Cytidine Acetylation

Project description:We show that NAT10-ac4C axis significantly regulates cell fates. To identify the molecular mechanisms of NAT10-ac4C-ANP32B axis in cell-fate transitions, we construct shNAT10 and shANP32B hESCs. acRIP-seq of shCTR and shNAT10 hESCs. We profiled ATAC-seq in shCTR, shNAT10, and shANP32B hESCs. We profiled H3K4me3 and H3K27me3 modifications and the binding of ANP32B by CUT&Tag in shCTR and shNAT10 hESCs.

2023-11-11 | GSE210504 | GEO

NAT10-mediated ac4C-modification exacerbates ferroptosis by stabilizing HMOX1 in Deep vein thrombosis [acRIP-Seq]

Project description:In our study, we aimed to identify the mechanisms closely related to ac4C. Through acRIP-seq analysis, we found that NAT10 enhances the stability of HMOX1 via ac4C modification, which leads to iron overload and lipid peroxides. This forms a positive feedback loop that exacerbates DVT.

2026-01-28 | GSE307103 | GEO

NAT10 promotes the progression of clear cell renal cell carcinoma by regulating ac4C acetylation of NFE2L3 and activating AKT/GSK3β signaling pathway

Project description:To determine the role of NAT10 in promoting the progression of ccRCC, we performed RNA sequencing (RNA-Seq) and ac4C-modified RNA immunoprecipitation sequencing (acRIP-seq) on four pairs of ccRCC tissues and their adjacent tissues. A comprehensive analysis of acRIP-seq and RNA-seq showed that the expression and acetylation levels of 199 transcripts were increased . We selected 11 candidate genes of interest and analyzed their acetylation levels. Since ac4C modification can improve mRNA stability, the 11 candidate genes were verified, and the results showed that only NFE2L3 mRNA levels decreased in 786-O cells and A498 cells after NAT10 stable knockdown , so we decided to study the mechanism of action of NFE2L3 in ccRCC.

2023-03-18 | GSE226863 | GEO